SLC12A7 serves as a prognostic and immunotherapeutic biomarker identified by multi-omics analysis
These findings identify SLC12A7 as a potential prognostic biomarker and immunotherapeutic target across cancers. Its oncogenic role in HCC suggests clinical utility in guiding prognosis and treatment strategies.
Authors
- Guohao Wang (ORCID: https://orcid.org/0000-0003-0922-7490)
- Haoran Qu
- Jun Sun
- Xiaoming Li
- Shuhong Ding
Institutions
- Pancreatic Cancer Action Network (US)
- Second Hospital of Shandong University (CN)
- Qilu Hospital of Shandong University (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2026-01-26
- DOI
- https://doi.org/10.3389/fimmu.2025.1712579
- Primary Topic
- Ion Transport and Channel Regulation
- Type
- article
- Field-Weighted Citation Impact
- 0.00